InvivoGen
InvivoGen was founded in 1997 by scientists with technical expertise and creative excellence stemming from a longstanding history in microbiology. InvivoGen's unparalleled skill in microbial fermentation enables them to provide a wide range of biological molecules, including ultra-pure antibiotics, novel mycoplasma treatments and the largest collection of pattern recognition receptor agonists derived from a wide range of micro-organisms.
More information at https://www.invivogen.com.
InvivoGen
SEAP reporter 293 cells expressing the human TLR2 and TLR1 genes
InvivoGen
SEAP reporter 293 cells expressing the human TLR2 and TLR6 genes
InvivoGen
SEAP reporter 293 cells expressing human TLR2 with a TLR1 and TLR6 double knockout
